Reuters logo
BRIEF-U.S. FDA approves Pfizer's Mylotarg for treatment of acute myeloid leukemia
September 1, 2017 / 3:21 PM / 19 days ago

BRIEF-U.S. FDA approves Pfizer's Mylotarg for treatment of acute myeloid leukemia

Sept 1 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA approves Pfizer’s Mylotarg for treatment of acute myeloid leukemia

* Prescribing information for Mylotarg includes a boxed warning that severe or fatal liver damage occurred in some patients who took mylotarg​

* Also approved Mylotarg for patients aged 2 years, older with CD33-positive AML experiencing relapse/ who have not responded to initial treatment​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below